Edwards Lifesciences EBITDA vs. Gross Profit
| EW Stock | USD 73.39 2.49 3.51% |
EBITDA | First Reported 2010-12-31 | Previous Quarter 1.5 B | Current Value 1.6 B | Quarterly Volatility 652.5 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.54 | 0.7702 |
|
| |||||
| Net Profit Margin | 0.25 | 0.2335 |
|
| |||||
| Operating Profit Margin | 0.16 | 0.2555 |
|
| |||||
| Pretax Profit Margin | 0.14 | 0.2661 |
|
| |||||
| Return On Assets | 0.078 | 0.1498 |
|
| |||||
| Return On Equity | 0.11 | 0.2109 |
|
|
For Edwards Lifesciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Edwards Lifesciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Edwards Lifesciences Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Edwards Lifesciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Edwards Lifesciences Corp over time as well as its relative position and ranking within its peers.
Edwards |
Edwards Lifesciences' Revenue Breakdown by Earning Segment
Check out Investing Opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 7.161 | Earnings Share 2.59 | Revenue Per Share 10.498 | Quarterly Revenue Growth 0.089 | Return On Assets 0.1065 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Edwards Lifesciences Corp Gross Profit vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Edwards Lifesciences's current stock value. Our valuation model uses many indicators to compare Edwards Lifesciences value to that of its competitors to determine the firm's financial worth. Edwards Lifesciences Corp is rated below average in ebitda category among its peers. It also is rated below average in gross profit category among its peers fabricating about 2.81 of Gross Profit per EBITDA. At this time, Edwards Lifesciences' EBITDA is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Edwards Lifesciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Edwards Gross Profit vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Edwards Lifesciences |
| = | 1.53 B |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Edwards Lifesciences |
| = | 4.3 B |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Edwards Gross Profit Comparison
Edwards Lifesciences is currently under evaluation in gross profit category among its peers.
Edwards Lifesciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Edwards Lifesciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Edwards Lifesciences will eventually generate negative long term returns. The profitability progress is the general direction of Edwards Lifesciences' change in net profit over the period of time. It can combine multiple indicators of Edwards Lifesciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -242.8 M | -230.7 M | |
| Operating Income | 1.5 B | 1.6 B | |
| Income Before Tax | 1.6 B | 1.7 B | |
| Total Other Income Expense Net | 64 M | 67.2 M | |
| Net Income | 1.4 B | 1.5 B | |
| Income Tax Expense | 198.7 M | 113.1 M | |
| Net Income Applicable To Common Shares | 1.8 B | 1.8 B | |
| Net Income From Continuing Ops | 1.4 B | 836.3 M | |
| Non Operating Income Net Other | 43.8 M | 46 M | |
| Net Interest Income | 40.7 M | 42.7 M | |
| Interest Income | 67.2 M | 70.6 M | |
| Change To Netincome | -56.5 M | -53.6 M | |
| Net Income Per Share | 2.31 | 2.43 | |
| Income Quality | 0.64 | 0.61 | |
| Net Income Per E B T | 0.88 | 0.65 |
Edwards Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Edwards Lifesciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Edwards Lifesciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Edwards Lifesciences' important profitability drivers and their relationship over time.
Use Edwards Lifesciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edwards Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will appreciate offsetting losses from the drop in the long position's value.Edwards Lifesciences Pair Trading
Edwards Lifesciences Corp Pair Trading Analysis
The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.
The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Edwards Lifesciences position
In addition to having Edwards Lifesciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Management Thematic Idea Now
Management
Companies providing management services to businesses. The Management theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Management Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Edwards Stock Analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.